BioCentury
ARTICLE | Financial News

Fate Therapeutics proposes IPO

August 19, 2013 7:00 AM UTC

Fate Therapeutics Inc., San Diego, Calif. Business: Gene/Cell therapy, Cancer, Musculoskeletal Date announced: 8/13/13 Type: IPO To be raised: Up to $69 million Shares: TBD Price: TBD Underwriters: Co...